- Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress Eli Lilly and Company
- Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand WSJ
- Eli Lilly Q2 2026 earnings beat, raises full-year revenue forecast qz.com
- Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth Reuters
- Here’s How Much Traders See Eli Lilly Stock Moving After Earnings Investopedia
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь